FEMTOBIOMED

femtobiomed-logo

Femtobiomed is a research and delivery platform for the development of anti-cancer treatment drugs.

#SimilarOrganizations #Website #More

FEMTOBIOMED

Social Links:

Industry:
Biopharma Biotechnology Medical Nanotechnology

Founded:
2011-07-01

Address:
Seongnam, Kyonggi-do, South Korea

Country:
South Korea

Website Url:
http://www.femtobiomed.com

Total Employee:
11+

Status:
Active

Contact:
(+82) 031-622-8501

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business PHP Google GStatic Google Static Content


Similar Organizations

inventage-lab-logo

Inventage lab

Inventory Lab is a Next-generation drug delivery platform using innovative manufacturing method.

Official Site Inspections

http://www.femtobiomed.com Semrush global rank: 6.94 M Semrush visits lastest month: 682

  • Host name: 183.111.169.45
  • IP address: 183.111.169.45
  • Location: South Korea
  • Latitude: 37.5112
  • Longitude: 126.9741
  • Timezone: Asia/Seoul

Loading ...

More informations about "Femtobiomed"

FEMTOBIOMED

Compatible with Femtobiomed CellShot WSC(Wide-scale Cartridge) Release Date - 2023.06. SSC-111. Cartridge specification. Processed volume (mL) : 0.33; Processed cell volume (10 6 …See details»

Femtobiomed - Crunchbase Company Profile & Funding

Femtobiomed is funded by ActnerLab. When was the last funding round for Femtobiomed? Femtobiomed closed its last funding round on Jan 1, 2015 …See details»

Femtobiomed Inc. - LinkedIn

Femtobiomed is a cell engineering device manufacturing company built upon CellShot®, employing the patented ‘Partitioned Flow Transfection’.See details»

Femtobiomed Inc. (XKON: 327610) Company Profile & Overview

Jan 20, 2025 Femtobiomed Inc. engages in the development of cargo-free intracellular delivery platform. The company, through its platform, CELLSHOT, is working on cell-based therapeutic …See details»

Femtobiomed 2025 Company Profile: Stock …

What industry is Femtobiomed in? Femtobiomed’s primary industry is Biotechnology. Is Femtobiomed a private or public company? Femtobiomed is …See details»

Femtobiomed Inc. Overview | SignalHire Company Profile

Femtobiomed is a cell engineering device manufacturing company built upon CellShot®, employing the patented ‘Partitioned Flow Transfection’. ... Using a multiple port cartridge, the …See details»

FEMTOBIOMED Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for FEMTOBIOMED Inc. of Seongnam, Gyeonggi. Get the latest business insights from Dun & …See details»

Femtobiomed - Funding, Financials, Valuation & Investors

Jan 1, 2015 Femtobiomed is a research and delivery platform for the development of anti-cancer treatment drugs.See details»

Femtobiomed, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Explore Femtobiomed, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Neoplasms, Technology Platform:Therapeutic vaccine, Drug:B-cell …See details»

Femtobiomed Inc - Company Profile and News - Bloomberg Markets

Company profile page for Femtobiomed Inc including stock price, company news, executives, board members, and contact informationSee details»

Femtobiomed, Inc. - Patsnap

Femtobiomed, Inc. is headquartered in South Korea Gyeonggi-do. Femtobiomed, Inc. was founded in 2011. Femtobiomed, Inc. has a total of 48 patents . Related Topics. Cell therapy …See details»

Femtobiomed - Tech Stack, Apps, Patents & Trademarks

Femtobiomed is a research and delivery platform for the development of anti-cancer treatment drugs. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. …See details»

Femtobiomed - Overview, News & Similar companies - ZoomInfo

Femtobiomed is a cell engineering device manufacturing company built upon CellShot®, employing the patented ‘Partitioned Flow Transfection’. Using a multiple port cartridge, the …See details»

Company Femtobiomed Inc. - MarketScreener.com

Company Femtobiomed Inc. Equities A327610 KR7327610002 Biotechnology & Medical Research End-of-day quote Korea S.E. Other stock markets. 2025-03-21 5-day change ...See details»

Femtobiomed - Products, Competitors, Financials, Employees ...

Femtobiomed's technology primarily serves the biomedical research and clinical therapy industries, providing tools to improve the delivery and efficacy of cell-based treatments. It was …See details»

About Femtobiomed Inc (327610) - Investing.com

This page offers an in-depth profile of Femtobiomed Inc, including a general overview of the company's business and key management. Breaking News . Quotes. All Instrument Types.See details»

Femtobiomed | Nanotechnology Company | NPD

Femtobiomed is a research and delivery platform for the development of anti-cancer treatment drugs. Analytical Reports No. Nanomaterials Used in Products by Industrial Divisions No. …See details»

Femtobiomed Inc. Stock (A327610) - Quote Korea S.E.

Femtobiomed Inc. announced that it expects to receive KRW 2.999996625 billion in funding from Korea Investment Partners Co. Ltd. 24-03-24: CI Femtobiomed Inc. announced that it has …See details»

B-cell based antigen vaccine - Femtobiomed - AdisInsight - Springer

Nov 28, 2023 21 Oct 2019 Femtobiomed files for patent protection for Cell Shot delivery technology in South Korea (Femtobiomed company website, October 2019) You need to be a …See details»

SmartDrop - Crunchbase Company Profile & Funding

Organization. SmartDrop . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone …See details»

linkstock.net © 2022. All rights reserved